Fusobacterium nucleatum and response to treatment in colon and rectal cancer: a systematic review
{{output}}
Fusobacterium nucleatum (Fn) has been implicated in the progression of colorectal cancer (CRC), immune modulation, and resistance to systemic therapies. However, its role as a predictive biomarker of treatment response remains unclear. We conducted a systemati... ...
